Quinoline derivatives as NK3 antagonists
US6743804B2 · kind B2 · utility
5Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2002 |
| Grant date | Jun 1, 2004 |
| Priority date | — |
| Expiry date | May 7, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel use, in particular a novel pharmaceutical use for a series of quinoline derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.